查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1571574

勝胜肽合成市場規模、佔有率和趨勢分析報告：2024-2030 年按產品、應用、技術、最終用途、地區和細分市場進行的預測

Peptide Synthesis Market Size, Share & Trends Analysis Report By Product (Equipment, Reagents & Consumables), By Application (Therapeutics, Diagnosis), By Technology, By End Use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

勝胜肽合成市場成長與趨勢：

Grand View Research, Inc.的最新報告顯示，預計2030年全球胜肽合成市場規模將達到14億美元，2024年至2030年複合年成長率為12.7%。

針對胜肽療法開發的重大研究和創新將在不久的將來推動市場成長。此外，胜肽合成技術的不斷進步預計將為在市場上企業發展的公司提供利潤豐厚的機會。

近年來，客自訂胜肽合成的需求激增，該行業的多家公司都提供與自訂胜肽合成相關的產品和服務。例如，英國的 Almac Group 提供適合研究應用的勝胜肽合成。對客自訂胜肽不斷成長的需求和不斷變化的市場格局將為市場成長提供利潤豐厚的機會。供應商正在提高產能，以滿足研究和治療領域對高品質勝胜肽不斷成長的需求。

製藥公司對新型生技藥品開發的日益關注以及勝胜肽藥物從管道階段向商業規模的轉變將進一步加強市場成長。越來越多的研究活動探索高品質勝胜肽和胜肽庫在疫苗開發和生物標記發現中的潛力，為全球胜肽合成市場的收益做出了重大貢獻。此外，市場上引入具有增強穩定性和藥物動力學特性的修飾胜肽（GMP胜肽）預計將在整個預測期內維持兩位數的市場成長。

近年來，由於患有心血管和代謝疾病的患者數量顯著增加，治療性勝胜肽的開發經歷了顯著成長。這大大加速了生物活性勝胜肽的發現，進一步刺激了市場需求。

胜肽合成市場報告亮點

  • 試劑和耗材在 2023 年的收益最高，預計這一趨勢將在預測期內持續下去。
  • 胜肽合成器在預測期內成長最快。
  • 勝胜肽合成儀領域對全球市場的設備收益貢獻龐大，預計2024年至2030年複合年成長率將在其他勝胜肽合成儀中最高，達13.6%。
  • 液相胜肽合成 (LPPS) 技術預計將在 2023 年主導勝胜肽合成市場，並在整個預測期內繼續保持這種主導地位。
  • 預計治療性勝胜肽合成將在 2023 年佔據市場最大佔有率，並在整個預測期內保持這一趨勢。
  • 北美地區在 2023 年的收益最高，預計在整個預測期內將保持這一主導地位。大量熟練的專業人員以及強大的勝胜肽合成製造商網路有助於該地區在全球市場中佔據主導地位。
  • 由於越來越重視開拓胜肽療法的新興市場，預計亞太地區將提供市場擴張的機會。
  • 亞太地區心血管和代謝疾病患者人數眾多，對收益貢獻巨大，導致預測期內複合年成長率最高。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第 3 章勝胜肽合成市場變數、趨勢、範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 胜肽合成市場分析工具
    • 波特的分析
    • PESTEL分析

第4章胜肽合成市場：依產品分類的預估及趨勢分析

  • 細分儀表板
  • 勝胜肽合成市場：2023 年和 2030 年按產品分類的變化分析
  • 裝置
  • 試劑/耗材
  • 服務

第5章胜肽合成市場：依技術估算及趨勢分析

  • 細分儀表板
  • 勝胜肽合成市場：2023 年和 2030 年技術變化分析
  • 固相勝胜肽合成（SPPS）
  • 液相胜肽合成（LPPS）
  • 混合技術

第6章勝胜肽合成市場：依應用估算及趨勢分析

  • 細分儀表板
  • 勝胜肽合成市場：2023 年和 2030 年按應用分類的變化分析
  • 治療藥物
    • 癌症
    • 代謝
    • 心血管疾病
    • 呼吸系統
    • GIT（胃腸道疾病）
    • 感染疾病
    • 疼痛
    • 皮膚
    • 中樞神經系統
    • 腎
    • 其他
  • 診斷
  • 研究

第7章勝胜肽合成市場：依最終用途分類的估算與趨勢分析

  • 細分儀表板
  • 勝胜肽合成市場：2023 年和 2030 年最終用途的變化分析
  • 製藥和生物技術公司
  • 合約開發和製造組織/合約研究組織
  • 學術研究所

第8章胜肽合成市場：區域估計和趨勢分析

  • 勝胜肽合成市場佔有率：按地區分類，2023 年和 2030 年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 科威特

第9章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • GenScript
    • Bachem Holding AG
    • Biotage
    • Creative Diagnostics
    • PolyPeptide Group
    • Syngene International Limited
    • Puresynth Research Chemicals Pvt Ltd.
    • Lonza
簡介目錄
Product Code: GVR-3-68038-697-4

Peptide Synthesis Market Growth & Trends:

The global peptide synthesis market size is expected to reach USD 1.4 billion by 2030 growing at a CAGR of 12.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. Significant research and innovation targeted towards the development of peptide therapeutics is set to boost the market growth in the near future. Additionally, increasing advancements in the peptide synthesis technologies is expected to offer profitable opportunities for the companies operating in the market.

A surge in the demand for custom peptide synthesis has been observed in the recent years; several companies operating in this industry offer products and services associated with custom peptide synthesis. For instance, a UK based company namely, Almac Group offers peptide synthesis suitable for research use. Constantly growing demand and evolving market landscape for custom peptides is set to offer lucrative opportunities for the market growth. The suppliers are expanding their production capacity to suffice the increasing demand for high quality peptides across research and therapeutics areas.

Rising focus of the pharmaceutical companies towards the development of novel biologics and shifting the peptide drugs from the pipeline stage to commercial scale further strengthens the market growth. Increase in the number of research activities performed on exploring the potential of high-quality peptides and peptide libraries in the development of vaccines and biomarker discovery heavily contributes to the revenue generated by the global peptide synthesis market. Moreover, introduction of modified peptides (GMP peptides) that possess enhanced stability and pharmacokinetic properties in the market is expected to maintain the double-digit market growth throughout the forecast period.

Therapeutic peptide development has witnessed remarkable growth in the recent years, this is further driven by significant increase in the patient pool suffering from cardiovascular and metabolic diseases. This has propelled the discovery of bioactive peptides exponentially which further drives the market demand.

Peptide Synthesis Market Report Highlights:

  • Reagents & consumables accounted for the highest revenue generated in 2023 and is anticipated to maintain this trend throughout the forecast period.
  • Peptide synthesis equipment has registered fastest growth during the forecast period
  • Peptide synthesizers segment serves to be a major contributor to the revenue generated by equipment in the global market and is anticipated to grow at highest CAGR of 13.6% from 2024 to 2030 among other peptide synthesis equipment.
  • Liquid phase peptide synthesis (LPPS) technology dominated the peptide synthesis market in 2023 and is expected to continue this dominance throughout the forecast period.
  • Therapeutic peptide synthesis has garnered the largest share in the market in 2023 and is anticipated to maintain this trend throughout the forecast period.
  • North America region has generated highest revenue in 2023 and is expected to maintain this dominance throughout the forecast period; sufficient presence of skilled professionals along with the strong network of peptide synthesis manufacturers is attributive to this region's dominance in the global market.
  • APAC is expected to offer lucrative opportunities for the market expansion, attributed to rising focus on the development of peptide therapeutics.
  • Large patient pool for cardiovascular and metabolic diseases in the APAC region has significantly contributed to the revenue generated, contributing to the highest CAGR registered during the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Peptide Synthesis Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Peptide Synthesis Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Peptide Synthesis Market: product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Peptide Synthesis Market Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Equipment
    • 4.3.1. Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Peptide Synthesizers
      • 4.3.2.1. Peptide Synthesizers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Lyophilizers
      • 4.3.3.1. Lyophilizers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. Chromatography Equipment
      • 4.3.4.1. Chromatography Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.5. Others
      • 4.3.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Reagents & Consumables
    • 4.4.1. Reagents & Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Resins
      • 4.4.2.1. Resins Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Amino Acids
      • 4.4.3.1. Amino Acids Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Coupling Reagents
      • 4.4.4.1. Coupling Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.5. Dyes & Fluroscent Labeling Reagents
      • 4.4.5.1. Dyes & Fluroscent Labeling reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.6. Others
      • 4.4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Services
    • 4.5.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Peptide Synthesis Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Peptide Synthesis Market: Technology Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Solid Phase Peptide Synthesis (SPPS)
    • 5.3.1. Solid Phase Peptide Synthesis (SPPS) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Liquid Phase Peptide Synthesis (LPPS)
    • 5.4.1. Liquid Phase Peptide Synthesis (LPPS) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Hybrid Technology
    • 5.5.1. Hybrid Technology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Peptide Synthesis Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Peptide Synthesis Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Therapeutics
    • 6.3.1. Therapeutics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. Cancer
      • 6.3.2.1. Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Metabolic
      • 6.3.3.1. Metabolic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. Cardiovascular Disorder
      • 6.3.4.1. Cardiovascular Disorder Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Respiratory
      • 6.3.5.1. Respiratory Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. GIT (Gastrointestinal Disorders)
      • 6.3.6.1. GIT (Gastrointestinal Disorders) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Infectious Diseases
      • 6.3.7.1. Infectious Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Pain
      • 6.3.8.1. Pain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Dermatology
      • 6.3.9.1. Dermatology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.10. CNS
      • 6.3.10.1. CNS Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.11. Renal
      • 6.3.11.1. Renal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.12. Others
      • 6.3.12.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Diagnosis
    • 6.4.1. Diagnosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Research
    • 6.5.1. Research Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Peptide Synthesis Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Peptide Synthesis Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  • 7.3. Pharmaceutical & Biotechnology Companies
    • 7.3.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Contract Development & Manufacturing Organization/Contract Research Organization
    • 7.4.1. Contract Development & Manufacturing Organization/Contract Research Organization Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Academic & Research Institutes
    • 7.5.1. Academic & Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Peptide Synthesis Market: Regional Estimates & Trend Analysis

  • 8.1. Peptide Synthesis Market Share, By Region, 2023 & 2030, USD Million
  • 8.2. North America
    • 8.2.1. North America Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.3. Canada
      • 8.2.3.1. Canada Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. UK Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Germany Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.4. France
      • 8.3.4.1. France Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.5. Italy
      • 8.3.5.1. Italy Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.6. Spain
      • 8.3.6.1. Spain Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.7. Denmark
      • 8.3.7.1. Denmark Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.8. Sweden
      • 8.3.8.1. Sweden Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.9. Norway
      • 8.3.9.1. Norway Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. China
      • 8.4.2.1. China Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Japan
      • 8.4.3.1. Japan Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. India Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. South Korea
      • 8.4.5.1. South Korea Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. Australia
      • 8.4.6.1. Australia Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.7. Thailand
      • 8.4.7.1. Thailand Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Argentina
      • 8.5.3.1. Argentina Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Middle East and Africa
    • 8.6.1. Middle East and Africa Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. Saudi Arabia
      • 8.6.2.1. Saudi Arabia Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. UAE
      • 8.6.3.1. UAE Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. South Africa
      • 8.6.4.1. South Africa Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Heat Map Analysis
  • 9.4. Company Profiles
    • 9.4.1. Thermo Fisher Scientific Inc.
      • 9.4.1.1. Participant's Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Recent Developments/Strategic Initiatives
    • 9.4.2. Merck KGaA
      • 9.4.2.1. Participant's Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Recent Developments/Strategic Initiatives
    • 9.4.3. GenScript
      • 9.4.3.1. Participant's Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Recent Developments/Strategic Initiatives
    • 9.4.4. Bachem Holding AG
      • 9.4.4.1. Participant's Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Recent Developments/Strategic Initiatives
    • 9.4.5. Biotage
      • 9.4.5.1. Participant's Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Recent Developments/Strategic Initiatives
    • 9.4.6. Creative Diagnostics
      • 9.4.6.1. Participant's Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Recent Developments/Strategic Initiatives
    • 9.4.7. PolyPeptide Group
      • 9.4.7.1. Participant's Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Recent Developments/Strategic Initiatives
    • 9.4.8. Syngene International Limited
      • 9.4.8.1. Participant's Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Recent Developments/Strategic Initiatives
    • 9.4.9. Puresynth Research Chemicals Pvt Ltd.
      • 9.4.9.1. Participant's Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Recent Developments/Strategic Initiatives
    • 9.4.10. Lonza
      • 9.4.10.1. Participant's Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Recent Developments/Strategic Initiatives